Advertisement
U.S. markets closed

Invivyd, Inc. (IVVD)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
4.3200+0.2800 (+6.93%)
At close: 04:00PM EST
4.2000 -0.12 (-2.78%)
After hours: 08:00PM EST
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Commodity Channel Index

Commodity Channel Index

Previous Close4.0400
Open4.0700
Bid4.0400 x 800
Ask4.5000 x 1200
Day's Range4.0250 - 4.3800
52 Week Range0.9800 - 5.1950
Volume257,441
Avg. Volume1,861,813
Market Cap513.415M
Beta (5Y Monthly)0.74
PE Ratio (TTM)N/A
EPS (TTM)-1.5500
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est7.67
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued

Subscribe to Yahoo Finance Plus to view Fair Value for IVVD

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • Invivyd, Inc.
    Daily – Vickers Top Insider Picks for 03/08/2023The Vickers Top Insider Picks is a daily report that utilizes a proprietary algorithm to identify 25 companies with compelling insider purchase histories based on transactions over the past three months.
    Rating
    Fair Value
    Economic Moat
    last yearArgus Research
View more
  • GlobeNewswire

    Invivyd to Participate at the Guggenheim Healthcare Talks 6th Annual Biotechnology Conference

    WALTHAM, Mass., Feb. 05, 2024 (GLOBE NEWSWIRE) -- Invivyd, Inc. (Nasdaq: IVVD), a biopharmaceutical company on a mission to protect the vulnerable from serious viral infectious diseases, today announced that David Hering, Chief Executive Officer of Invivyd, is scheduled to present in a fireside chat at the Guggenheim Healthcare Talks 6th Annual Biotechnology Conference on Thursday, February 8, 2024 at 1:00 p.m. ET in New York, NY. In addition to the fireside chat, the management team will host i

  • InvestorPlace

    3 Groundbreaking Biotech Stocks to Invest in Now

    Biotechnology companies are intriguing investment vehicles because they are part of a pretty speculative industry that allows investors to grow their investments rapidly — if they pick a company before it releases positive results. But on the flip side, a single negative press release could send a stock tumbling with biotech stocks being so volatile. Overall, it is an industry that average investors should tread through lightly, but for investors looking for dramatic growth potential, the biotec

  • Simply Wall St.

    When Will Invivyd, Inc. (NASDAQ:IVVD) Become Profitable?

    We feel now is a pretty good time to analyse Invivyd, Inc.'s ( NASDAQ:IVVD ) business as it appears the company may be...